Ticagrelor Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Percutaneous Coronary Intervention: The PL-PLATELET Randomized Trial
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms PL-PLATELET
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.
- 11 Jun 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jul 2017.
- 15 Mar 2017 Planned number of patients changed from 520 to 1050.